- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beyond Air Inc (XAIR)
Beyond Air Inc stock price live, this page displays NASDAQ XAIR stock exchange data. View the XAIR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beyond Air Inc real time stock price chart below.
What Is the Beyond Air Inc Stock Price Today?
The Beyond Air Inc stock price today is 3.200.
What Is the Stock Symbol for Beyond Air Inc?
The stock symbol for Beyond Air Inc is "XAIR."
What Stock Exchange Does Beyond Air Inc Trade On?
Beyond Air Inc is listed and trades on the NASDAQ stock exchange.
Is Beyond Air Inc a Good Stock to Buy?
Determining whether Beyond Air Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XAIR quote. (ISIN: US08862L3015)
What Is the Beyond Air Inc Stock Price Today?
The Beyond Air Inc stock price today is 3.200.
What Is the Stock Symbol for Beyond Air Inc?
The stock symbol for Beyond Air Inc is "XAIR."
What Stock Exchange Does Beyond Air Inc Trade On?
Beyond Air Inc is listed and trades on the NASDAQ stock exchange.
Is Beyond Air Inc a Good Stock to Buy?
Determining whether Beyond Air Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XAIR quote. (ISIN: US08862L3015)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.070
3.290
52 wk Range
3.063
55.600
XAIR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.0703.290
52 wk Range
3.06355.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XAIR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
20.000
Upside
+525.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Form 8K Beyond Air Inc For: 18 August- Investing.com
AIT Therapeutics receives Investment Bank Analyst Rating Update- Investing.com
Pro
- AIT Therapeutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 20.000
(+525.00% Upside)
Beyond Air Inc SWOT Analysis
Innovative NO Delivery | Beyond Air's LungFit PH system generates nitric oxide from room air, potentially disrupting the $700 million global market for NO delivery systems |
Financial Hurdles | Explore Beyond Air's strategy to overcome significant cash burn and reach cash flow breakeven by fiscal year 2027, despite lowered revenue projections |
Market Expansion Plans | Learn about Beyond Air's efforts to expand LungFit PH's approved uses, including a pending FDA decision for cardiac surgeries and pursuit of CE mark in Europe |
Competitive Landscape | Delve into Beyond Air's positioning against dominant players like Mallinckrodt, with analyst price target at $2.00 amid market challenges and opportunities |
Beyond Air Inc Earnings Call Summary for Q1/2027
- Beyond Air reported Q1 FY2027 revenue of $1.77M, missing estimates of $2.21M by 19.9%; shares fell 7.11% premarket to $5.62.
- Gross margin improved to 13% from 9% YoY, marking third consecutive quarter of positive gross profit; R&D expenses declined 35.5%.
- Company reaffirmed FY2026 revenue guidance of $8M and FY2027 outlook of $16M-$18M, contingent on second-generation LungFit PH FDA approval.
- Management expects FDA decision on next-generation LungFit PH system in Q4 2026; secured $10M financing to fund commercial launch and expansion.
- Net loss widened to $7.9M from $7.7M YoY; commercial pipeline doubled in recent months but execution risks remain amid ongoing cash burn.
Last Updated: 08/13/2026, 09:18 PM
Read Full TranscriptEarnings
Latest Release
Aug 13, 2026
EPS / Forecast
-11.00 / -10.90
Revenue / Forecast
1.77M / 2.21M
Compare XAIR to Peers and Sector
Metrics to compare | XAIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXAIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −1.5x | −0.3x | |
PEG Ratio | 0.00 | −0.08 | 0.00 | |
Price/Book | 1.5x | 2.3x | 2.6x | |
Price / LTM Sales | 0.4x | 1.9x | 3.0x | |
Upside (Analyst Target) | - | 23.4% | 54.6% | |
Fair Value Upside | Unlock | 17.6% | 8.6% | Unlock |
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Beyond Air (XAIR) Stock Price Today?
The Beyond Air stock price today is 3.200 USD.
What Stock Exchange Does Beyond Air Trade On?
Beyond Air is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Beyond Air?
The stock symbol for Beyond Air is "XAIR."
What Is the Beyond Air Market Cap?
As of today, Beyond Air market cap is 2.940M USD.
What Is Beyond Air's Earnings Per Share (TTM)?
The Beyond Air EPS (TTM) is -62.875.
When Is the Next Beyond Air Earnings Date?
Beyond Air will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is XAIR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beyond Air Stock Split?
Beyond Air has split 3 times.
How Many Employees Does Beyond Air Have?
Beyond Air has 54 employees.
What is the current trading status of Beyond Air (XAIR)?
As of Sep 12, 2026, Beyond Air (XAIR) is trading at a price of 3.200 USD, with a previous close of 3.070 USD. The stock has fluctuated within a day range of 3.070 USD to 3.290 USD, while its 52-week range spans from 3.063 USD to 55.600 USD.
What Is Beyond Air (XAIR) Price Target According to Analysts?
The average 12-month price target for Beyond Air is 20.000 USD, with a high estimate of 30 USD and a low estimate of 10 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +525.00% Upside potential.
What Is the XAIR Premarket Price?
XAIR's last pre-market stock price is 3.143 USD. The pre-market share volume is 1,670.000, and the stock has decreased by 0.073, or 2.380%.
What Is the XAIR After Hours Price?
XAIR's last after hours stock price is 3.280 USD, the stock has decreased by 0.080, or 2.500%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.